Related Experiment Videos
Structural and functional features of the CD34 antigen: an update
F Lanza1, L Healy, D R Sutherland
1Section of Hematology, St Anna Hospital, University of Ferrara, Italy.
Summary
CD34, a sialomucin, has specific carbohydrate modifications crucial for its function. While HEV CD34 binds L-selectin, hematopoietic CD34 ligands remain unidentified.
Area of Science:
- Immunology
- Molecular Biology
- Glycobiology
Background:
- CD34 is a heavily glycosylated transmembrane molecule involved in cell interactions.
- Its structure and glycosylation are critical for ligand binding.
- Antibody selection for CD34 relies on epitope classification.
Purpose of the Study:
- To investigate the structural basis of CD34's interactions with ligands.
- To understand the role of glycosylation in CD34 function.
- To differentiate CD34 ligand interactions in various cell types.
Main Methods:
- Structural analysis and cloning studies.
- Glycosylation analysis using sialyl- and sulfo-transferases.
- Comparative studies of CD34 in high endothelial venules (HEV) and hematopoietic stem/progenitor cells (HSPCs).
Main Results:
- CD34 is confirmed as a sialomucin with N-terminal glycosylation influencing ligand interactions.
- HEV CD34 O-linked glycans are specifically modified for L-selectin binding.
- CD34 in HSPCs does not bind L-selectin, and its ligands are yet to be identified.
Conclusions:
- The specific O-linked glycan composition of CD34 dictates its ligand-binding properties.
- Differential glycosylation of CD34 in HEVs versus HSPCs leads to distinct functional roles.
- Further research is needed to identify ligands for hematopoietic CD34.